is tirzepatide on shortage 🚨 Alert: No Longer FDA's Drug List As of October 2, 2024, the FDA has announced that the Tirzepatide shortage has been resolved. This means that all doses of Lilly, Novo Fight Weight Loss

Berberine does not inhibit semaglutide metabolism or reduce its efficacy at the GLP-1 receptor

Patients carrying certain genetic variants may experience earlier symptom onset or longer adaptation periods, but they often achieve superior weight loss outcomes once the initial adjustment phase resolves

Skovbjerg et al., 2024)

This is usually due to: Lower calorie intake Reduced carbohydrate intake Overall lower energy availability You may notice: Slight decreases in strength Less endurance during workouts Reduced muscle pump During this phase, the goal should be: maintaining muscle and strength, not chasing new personal records

Since GLP-1s reduce blood sugar, they might help protect your eyesbut its complicated

Subscribers were up 41% in Q1 2025, to 1.7 million